4//SEC Filing
Gunderson Robert V JR 4
Accession 0001179110-20-005297
CIK 0001583107other
Filed
Apr 29, 8:00 PM ET
Accepted
Apr 30, 6:53 PM ET
Size
7.6 KB
Accession
0001179110-20-005297
Insider Transaction Report
Form 4
Gunderson Robert V JR
Director
Transactions
- Award
Ordinary Shares
2020-04-28+6,635→ 58,265 total - Award
Share Option (Right to Buy)
2020-04-28+6,000→ 6,000 totalExercise: $30.14Exp: 2030-04-27→ Ordinary Shares (6,000 underlying)
Holdings
- 10,847(indirect: By Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP)
Ordinary Shares
Footnotes (1)
- [F1]This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the Company's shareholders provided the optionee remains in continuous service on such date.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001302450
Filing Metadata
- Form type
- 4
- Filed
- Apr 29, 8:00 PM ET
- Accepted
- Apr 30, 6:53 PM ET
- Size
- 7.6 KB